Loading institutional data...
Loading institutional data...
Strong institutional distribution: ownership decreased -8.43% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76B 100.0% | $2.68B 100.0% | $2.55B 100.0% | $9.96B 100.0% | $9.79B 100.0% | $8.48B 100.0% | $9.21B 100.0% | $9.42B 100.0% | $9.32B 100.0% | $9.72B 100.0% |
| Cost of Revenue | $1.47B 53.3% | $1.40B 52.2% | $1.34B 52.3% | $8.13B 81.7% | $8.27B 84.5% | $7.20B 84.9% | $8.08B 87.7% | $8.35B 88.6% | $8.15B 87.4% | $8.54B 87.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $8.15B 87.4% | $8.54B 87.8% |
| Gross Profit | — | $2.22B 82.8% | $2.13B 83.3% | $1.83B 18.3% | $1.51B 15.5% | $1.28B 15.1% | $1.13B 12.3% | $1.07B 11.4% | $1.17B 12.6% | $1.19B 12.2% |
| Research & Development | — | $13.0M 0.5% | $13.0M 0.5% | $12.0M 0.1% | $12.1M 0.1% | — | — | — | — | — |
| Selling, General & Admin | $1.07B 38.7% | $1.08B 40.4% | $1.00B 39.2% | $1.55B 15.6% | $1.08B 11.0% | $1.04B 12.3% | $1.02B 11.1% | $952.9M 10.1% | $1.02B 10.9% | $970.4M 10.0% |
| Operating Income | $27.5M 1.0% | -$217.7M -8.1% | $133.2M 5.2% | $142.9M 1.4% | $368.5M 3.8% | $204.1M 2.4% | $73.2M 0.8% | -$352.3M -3.7% | $89.3M 1.0% | $199.6M 2.1% |
| Interest Expense | $107.2M 3.9% | $107.6M 4.0% | $116.8M 4.6% | $128.9M 1.3% | $48.1M 0.5% | $83.4M 1.0% | $98.1M 1.1% | $71.0M 0.8% | $31.8M 0.3% | $27.1M 0.3% |
| Other Income (Expense), net | -$3.9M -0.1% | -$4.6M -0.2% | -$1.2M -0.0% | -$3.1M -0.0% | -$3.2M -0.0% | $407K 0.0% | -$2.9M -0.0% | -$3.8M -0.0% | — | — |
| Pretax Income | -$102.0M -3.7% | -$329.9M -12.3% | $15.3M 0.6% | $10.9M 0.1% | $276.8M 2.8% | $109.9M 1.3% | -$28.7M -0.3% | -$427.1M -4.5% | $57.5M 0.6% | $172.5M 1.8% |
| Income Tax Expense | $729K 0.0% | $20.9M 0.8% | $6.4M 0.2% | -$11.5M -0.1% | $55.2M 0.6% | $21.8M 0.3% | -$6.1M -0.1% | -$32.4M -0.3% | -$15.3M -0.2% | $63.8M 0.7% |
| Net Income | -$1.10B -39.8% | -$362.7M -13.5% | -$41.3M -1.6% | $22.4M 0.2% | $221.6M 2.3% | $29.9M 0.4% | -$62.4M -0.7% | -$437.0M -4.6% | $72.8M 0.8% | $108.8M 1.1% |
| Per Share | ||||||||||
| EPS (Basic) | $-14.31 | $-4.73 | $-0.54 | $0.30 | $3.05 | $0.47 | $-1.03 | — | — | $1.76 |
| EPS (Diluted) | $-14.31 | $-4.73 | $-0.53 | $0.29 | $2.94 | $0.47 | $-1.03 | — | — | $1.76 |
| Weighted Avg Shares (Basic) | 76.9M | 76.7M | 75.8M | 74.5M | 72.7M | 63.4M | 60.6M | — | 60.0M | 61.1M |
| Weighted Avg Shares (Diluted) | 76.9M | 76.7M | 77.4M | 76.2M | 75.5M | 63.5M | 60.6M | — | 60.0M | 61.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
The answer is outside the range this solves over (-60% to +100%/yr), so it is reported as off the scale rather than as a rate. The price is below what this cash flow is worth even under collapse.
2-stage DCF · 0.08B shares · net debt -$32M
mean 63.6% · volatility σ 136% · implied rate exceeded in 5/8 yrs
Central path = implied -60.0%/yr growth; shaded band = ±1σ (136%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
2/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $10M buybacks = $10M returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 522%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $282M covers the $0 due within a year 281989000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2018-09-30 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~42.9% on $250M of debt.
Cash of $282M fully covers short-term debt of $250M.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 88.6 | 87.7 | 84.9 | 84.5 | 81.7 | 52.3 | 52.2 | 53.3 |
| Gross Profit | 11.4 | 12.3 | 15.1 | 15.5 | 18.3 | 83.3 | 82.8 | — |
| R&D | — | — | — | 0.1 | 0.1 | 0.5 | 0.5 | — |
| SG&A | 10.1 | 11.1 | 12.3 | 11.0 | 15.6 | 39.2 | 40.4 | 38.7 |
| Operating Income | -3.7 | 0.8 | 2.4 | 3.8 | 1.4 | 5.2 | -8.1 | 1.0 |
| Income Tax | -0.3 | -0.1 | 0.3 | 0.6 | -0.1 | 0.2 | 0.8 | 0.0 |
| Net Income | -4.6 | -0.7 | 0.4 | 2.3 | 0.2 | -1.6 | -13.5 | -39.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ACH: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| ACH | $79M | — | 0.2× | 0.0× | 3.1% | 46.7% | -39.8% | 239% | 522% | 1.0× | 140 |
Peers = companies sharing ACH's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.